#biopharma — Public Fediverse posts

Despite layoff announcements, Novartis beats Q2 expectations   — GoodRx teams with Boehringer on Humira biosimilar— Medtech firms have cut more than 14,000 jobs in the past 18 months —http://bit.ly/w28kSd #novartis #earnings #layoffs #humira #biosimilar #goodrx #abbvie #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Despite layoff announcements, Novartis beats Q2 expectations   — GoodRx teams with Boehringer on Humira biosimilar— Medtech firms have cut more than 14,000 jobs in the past 18 months —http://bit.ly/w28kSd #novartis #earnings #layoffs #humira #biosimilar #goodrx #abbvie #medtech #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales—Humira biosimilar scripts take off—Intra-Cellular launches 26% to record high, breaking out after depression drug scores big--http://bit.ly/w28kSd #earnings #jnj #abbvie #humira #biosimilars #depression #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales—Humira biosimilar scripts take off—Intra-Cellular launches 26% to record high, breaking out after depression drug scores big--http://bit.ly/w28kSd #earnings #jnj #abbvie #humira #biosimilars #depression #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

5 successful phase III oncology trials in Q1—FDA gives nod to BrainStorm for ALS trial after Phase III flop—AbbVie’s Humira loses only 4% of market share to biosimilars--http://bit.ly/w28kSd #clinicaltrials #oncology #fda #als #abbvie #humira #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

5 successful phase III oncology trials in Q1—FDA gives nod to BrainStorm for ALS trial after Phase III flop—AbbVie’s Humira loses only 4% of market share to biosimilars--http://bit.ly/w28kSd #clinicaltrials #oncology #fda #als #abbvie #humira #biosimilars #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

BMS more likely to bet on bolt-ons after recent buying spree—As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B — Brain drug developer Alto Neuroscience prices $129M IPO--http://bit.ly/w28kSd #bristolmyerssquibb #mergersandacquisitions #abbvie #earnings #humira #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

BMS more likely to bet on bolt-ons after recent buying spree—As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B — Brain drug developer Alto Neuroscience prices $129M IPO--http://bit.ly/w28kSd #bristolmyerssquibb #mergersandacquisitions #abbvie #earnings #humira #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie’s Humira maintains market dominance amid biosimilar launches —Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant' job cuts — Novartis ends phase III peanut allergy trial --http://bit.ly/w28kSd #biosimilars #humira #abbvie #bayer #restructuring #layoffs #novartis #clinicaltrials #peanutallergy #novartis #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

CVS to remove AbbVie’s Humira from reimbursement lists, cover biosimilars-- Lilly launches website, home delivery option for weight-loss drugs— Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals --http://bit.ly/w28kSd #cvs #abbvie #biosimilars #humira #weightloss #elililly #novonordisk #mash #nash #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Roche joins obesity drug chase with $2.7B deal for startup Carmot-- Humira biosimilars not gaining traction --JNJ hires thousands, invests millions in AI-powered drug discovery --http://bit.ly/w28kSd #roche #mergersandacquisitions #obesity #humira #biosimilars #abbvie #jnj #ai #drugdiscovery #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims -- Third time might be the charm for Alvotech's Humira biosimilar -- Roche scores—again—in hemophilia drug patent case against Takeda -- See more on our front page news http://bit.ly/w28kSd #astrazeneca #remotework #legal #employmentlaw #alovtech #humira #abbvie #fda #biosimilars #roche #genenetech #takeda #patents #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's Humira to take hit from biosimilars, next-gen therapies -- Walgreens to pay $44M to settle claims over fraudulent Theranos tests -- AstraZeneca signs AI-powered drug discovery pact with Verge -- See more on our front page news http://bit.ly/w28kSd #abbvie #humira #biosimilars #walgreens #theranos #legal #fraud #medtech #astrazeneca #ai #drugdiscovery #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Amgen clinches clinical wins in SCLC and colorectal cancer -- FDA approves Merck's Ebola vaccine for under-18s -- Amgen's hyped Humira biosimilar fritters away its exclusivity advantage -- See more on our front page news http://bit.ly/w28kSd #amgen #clinicaltrials #lungcancer #colorectalcancer #humira #biosimilars #vaccines #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Pfizer shuffles R&D leadership to prepare for Seagen merger -- Lilly's obesity drug leads to about 26% weight loss in new studies -- Biosimilar makers split strategies in bid to take on top-selling Humira -- See more on our front page news http://bit.ly/w28kSd #pfizer #mergersandacquisitions #seagen #researchanddevelopment #biosimilars #abbvie #humira #obesity #clinicaltrials #elililly #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Pfizer, Flagship join forces to hunt for 10 new drugs—Four crucial questions about the Humira biosimilar price war -- Medicare's proposed coverage for Alzheimer's scan could be boon for Eisai and Biogen -- See more on our front page news http://bit.ly/w28kSd #pfizer #flagshippioneering #humira #abbvie #drugdevelopment #alzheimers #biosimilar #medicare #cms #biogen #eisai #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

7 life science IPOs in 2023 — 7 companies are rolling out Humira biosimilars -- Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up 2 'Merck' showdowns -- See more on our front page news http://bit.ly/w28kSd #ipos #lifesciences #biosimilars #abbvie #humira #opdivo #bladdercancer #bristolmyerssquibb #merck #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

FDA rejects Teva’s high-potency biosimilar of Humira again — After a record run, fewer biotechs are going public— Sarepta shares drop as report says FDA almost rejected under-review gene therapy -- See more on our front page news http://bit.ly/w28kSd #tevapharma #fda #humira #abbvie #biosimilars #ipos #genetherapy #sarepta #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate — Amgen is sued for concealing $10.7 billion tax bill from investors— In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout -- See more on our front page news http://bit.ly/w28kSd #abbvie #pfizer #humira #drugpricing #inflation #taxes #amgen #legal #jnj #executivepay #ceos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GSK and Novartis report earnings — Amgen adopts a two-price strategy for first Humira biosimilar, Amjevita — Legislative hurdles anticipated for biopharma in 2023 -- See more on our front page news http://bit.ly/w28kSd #gsk #novartis #earnings #amgen #humira #abbvie #biosimilar #drugpricing #legislation #biopharma #biotech #biotechnology #pharma #pharmanews #cafepharma

Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block — The end of the Humira era — Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating -- See more on our front page news http://bit.ly/w28kSd #amgen #layoffs #humira #biosimilars #abbvie #biotech #pipeline #mentalhealth #mentalillness #depression #pharma #pharmanews #biotechnology #biopharma #cafepharma